Style | Citing Format |
---|---|
MLA | Pakdel A, et al.. "Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy." SAGE Open Medicine, vol. 13, no. , 2025, pp. -. |
APA | Pakdel A, Mohammadi A, Shamshirgaran A, Zemanati Yar E, Zareian Baghdadabad L, Alaeddini F, Koohi Ortakand R, Oliveira Reis L, Hosseini SR, Aghamir SMK (2025). Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy. SAGE Open Medicine, 13(), -. |
Chicago | Pakdel A, Mohammadi A, Shamshirgaran A, Zemanati Yar E, Zareian Baghdadabad L, Alaeddini F, Koohi Ortakand R, Oliveira Reis L, Hosseini SR, Aghamir SMK. "Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy." SAGE Open Medicine 13, no. (2025): -. |
Harvard | Pakdel A et al. (2025) 'Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy', SAGE Open Medicine, 13(), pp. -. |
Vancouver | Pakdel A, Mohammadi A, Shamshirgaran A, Zemanati Yar E, Zareian Baghdadabad L, Alaeddini F, et al.. Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy. SAGE Open Medicine. 2025;13():-. |
BibTex | @article{ author = {Pakdel A and Mohammadi A and Shamshirgaran A and Zemanati Yar E and Zareian Baghdadabad L and Alaeddini F and Koohi Ortakand R and Oliveira Reis L and Hosseini SR and Aghamir SMK}, title = {Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy}, journal = {SAGE Open Medicine}, volume = {13}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Pakdel A AU - Mohammadi A AU - Shamshirgaran A AU - Zemanati Yar E AU - Zareian Baghdadabad L AU - Alaeddini F AU - Koohi Ortakand R AU - Oliveira Reis L AU - Hosseini SR AU - Aghamir SMK TI - Operation Time As a Prognostic Indicator on Postoperative Complications Following Percutaneous Nephrolithotomy JO - SAGE Open Medicine VL - 13 IS - SP - EP - PY - 2025 ER - |